{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T05:32:17Z","timestamp":1780637537214,"version":"3.54.1"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,12]],"date-time":"2017-01-12T00:00:00Z","timestamp":1484179200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003134","name":"FRIA-FNRS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003134","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WT100321\/z\/12\/Z"],"award-info":[{"award-number":["WT100321\/z\/12\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Wiener Anspach"},{"name":"Marie Curie Actions","award":["TLR4-CAT PIEF-GA-2012-326481"],"award-info":[{"award-number":["TLR4-CAT PIEF-GA-2012-326481"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.jconrel.2016.12.029","type":"journal-article","created":{"date-parts":[[2016,12,28]],"date-time":"2016-12-28T19:30:25Z","timestamp":1482953425000},"page":"182-193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Toll-like receptor 2 promiscuity is responsible for the immunostimulatory activity of nucleic acid nanocarriers"],"prefix":"10.1016","volume":"247","author":[{"given":"Malvina","family":"Pizzuto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6131-0115","authenticated-orcid":false,"given":"Monique","family":"Gangloff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Scherman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Gay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Escriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marie","family":"Ruysschaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Lonez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2016.12.029_bb0005","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.175.4025.949","article-title":"Gene therapy for human genetic disease?","volume":"175","author":"Friedmann","year":"1972","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2016.12.029_bb0010","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1038\/mt.2012.194","article-title":"Endgame: glybera finally recommended for approval as the first gene therapy drug in the European Union","volume":"20","author":"Yl\u00e4-Herttuala","year":"2012","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0015","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1089\/humc.2016.29010.ind","article-title":"Investor outlook: rising from the ashes; GSK's European Approval of Strimvelis for ADA-SCID","volume":"27","author":"Schimmer","year":"2016","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0020","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/mt.2016.98","article-title":"ADA-SCID gene therapy endorsed by European Medicines Agency for marketing authorization","volume":"24","author":"Yl\u00e4-Herttuala","year":"2016","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0025","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/jcp.24791","article-title":"Gene therapies for cancer: strategies, challenges and successes","volume":"230","author":"Das","year":"2015","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2249.2003.02124.x","article-title":"Immunological hurdles to lung gene therapy","volume":"132","author":"Ferrari","year":"2003","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0035","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/sj.gt.3302364","article-title":"Immune responses to gene therapy vectors: influence on vector function and effector mechanisms","volume":"11","author":"Bessis","year":"2004","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0040","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1089\/hum.1997.8.17-2019","article-title":"Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression","volume":"8","author":"Qin","year":"1997","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0045","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/nature15818","article-title":"Gene therapy returns to centre stage","volume":"526","author":"Naldini","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2016.12.029_bb0050","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/jgm.2698","article-title":"Gene therapy clinical trials worldwide to 2012 - an update","volume":"15","author":"Ginn","year":"2013","journal-title":"J. Gene Med."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0055","unstructured":"Gene Therapy Clinical Trials Worldwide, (n.d.). http:\/\/www.abedia.com\/wiley\/ (accessed August 5, 2016)."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0060","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev.pharmtox.43.100901.140257","article-title":"Gene therapy with viral vectors","volume":"43","author":"Kootstra","year":"2003","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0065","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.biomaterials.2005.09.036","article-title":"Design of modular non-viral gene therapy vectors","volume":"27","author":"De Laporte","year":"2006","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.12.029_bb0070","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1208\/s12248-009-9143-y","article-title":"Nonviral gene delivery: principle, limitations, and recent progress","volume":"11","author":"Al-Dosari","year":"2009","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0075","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10565-009-9141-y","article-title":"Multifunctional nanocomplexes for gene transfer and gene therapy","volume":"26","author":"Hart","year":"2010","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0080","doi-asserted-by":"crossref","first-page":"7413","DOI":"10.1073\/pnas.84.21.7413","article-title":"Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure","volume":"84","author":"Felgner","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0085","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jconrel.2006.06.024","article-title":"Cationic lipids, lipoplexes and intracellular delivery of genes","volume":"116","author":"Wasungu","year":"2006","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0090","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0378-5173(99)00041-1","article-title":"Characterization of DNA-lipid complexes commonly used for gene delivery","volume":"183","author":"Zuidam","year":"1999","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0095","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0169-409X(97)00019-7","article-title":"Cationic lipids used in gene transfer","volume":"27","author":"Zabner","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0100","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1016\/j.biomaterials.2008.04.036","article-title":"Progress in developing cationic vectors for non-viral systemic gene therapy against cancer","volume":"29","author":"Morille","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.12.029_bb0105","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jconrel.2015.12.012","article-title":"Non-viral gene therapy: gains and challenges of non-invasive administration methods","volume":"240","author":"Foldvari","year":"2016","journal-title":"J. Control. Release"},{"issue":"160","key":"10.1016\/j.jconrel.2016.12.029_bb0110","first-page":"4580","article-title":"Cationic lipids enhance cytokine and cell influx levels in the lung following administration of plasmid: cationic lipid complexes","volume":"1950","author":"Freimark","year":"1998","journal-title":"J. Immunol. Baltim. Md"},{"key":"10.1016\/j.jconrel.2016.12.029_bb0115","doi-asserted-by":"crossref","first-page":"L796","DOI":"10.1152\/ajplung.1999.276.5.L796","article-title":"Effect of immune response on gene transfer to the lung via systemic administration of cationic lipidic vectors","volume":"276","author":"Li","year":"1999","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0120","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ijpharm.2007.06.012","article-title":"Innate immune response induced by gene delivery vectors","volume":"354","author":"Sakurai","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0125","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1089\/hum.1997.8.6-689","article-title":"Basis of pulmonary toxicity associated with cationic lipid-mediated gene transfer to the mammalian lung","volume":"8","author":"Scheule","year":"1997","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0130","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1189\/jlb.0204089","article-title":"Macrophage activation by a DNA\/cationic liposome complex requires endosomal acidification and TLR9-dependent and -independent pathways","volume":"77","author":"Yasuda","year":"2005","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0135","doi-asserted-by":"crossref","first-page":"9237","DOI":"10.1073\/pnas.161293498","article-title":"Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition","volume":"98","author":"Bauer","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0140","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0169-409X(00)00090-9","article-title":"The role of CpG motifs in immunostimulation and gene therapy","volume":"44","author":"Scheule","year":"2000","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0145","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/(SICI)1521-2254(199901\/02)1:1<56::AID-JGM5>3.3.CO;2-Y","article-title":"Direct immunologic activities of CpG DNA and implications for gene therapy","volume":"1","author":"Krieg","year":"1999","journal-title":"J. Gene Med."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0150","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1146\/annurev.immunol.20.100301.064842","article-title":"Cpg motifs in bacterial DNA and their immune effects","volume":"20","author":"Krieg","year":"2002","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0155","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.2174\/092986710791163957","article-title":"Recognition of nucleic acids by Toll-like receptors and development of immunomodulatory drugs","volume":"17","author":"Kuznik","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0160","article-title":"Microbial sensing by toll-like receptors and intracellular nucleic acid sensors","volume":"5","author":"P. S, K. T, A. S","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0165","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/nri3713","article-title":"Assembly and localization of toll-like receptor signalling complexes","volume":"14","author":"Gay","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0170","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1126\/science.1085536","article-title":"Toll-like receptor signaling pathways","volume":"300","author":"Barton","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2016.12.029_bb0175","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1046\/j.1365-2567.2003.01653.x","article-title":"Effect of cytofectins on the immune response of murine macrophages to mammalian DNA","volume":"109","author":"Zhu","year":"2003","journal-title":"Immunology"},{"key":"10.1016\/j.jconrel.2016.12.029_bb0180","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/sj.gt.3300540","article-title":"A new DNA vehicle for nonviral gene delivery: supercoiled minicircle","volume":"4","author":"Darquet","year":"1997","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0185","doi-asserted-by":"crossref","first-page":"23125","DOI":"10.1038\/srep23125","article-title":"Minicircle DNA provides enhanced and prolonged transgene expression following airway gene transfer","volume":"6","author":"Munye","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0190","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2741\/s256","article-title":"Development of safe and effective nonviral gene therapy by eliminating CpG motifs from plasmid DNA vector","volume":"4","author":"Takahashi","year":"2012","journal-title":"Front. Biosci. (Schol. Ed.)"},{"key":"10.1016\/j.jconrel.2016.12.029_bb0195","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1089\/oli.2008.0164","article-title":"Chemical modification of siRNAs for in vivo use","volume":"18","author":"Behlke","year":"2008","journal-title":"Oligonucleotides"},{"key":"10.1016\/j.jconrel.2016.12.029_bb0200","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1089\/104303401750148667","article-title":"A clinical inflammatory syndrome attributable to aerosolized lipid-DNA administration in cystic fibrosis","volume":"12","author":"Ruiz","year":"2001","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2015.04.024","article-title":"Efficient in vivo transfection and safety profile of a CpG-free and codon optimized luciferase plasmid using a cationic lipophosphoramidate in a multiple intravenous administration procedure","volume":"59","author":"Lindberg","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.12.029_bb0210","doi-asserted-by":"crossref","first-page":"9854","DOI":"10.1016\/j.biomaterials.2011.08.092","article-title":"The significance of plasmid DNA preparations contaminated with bacterial genomic DNA on inflammatory responses following delivery of lipoplexes to the murine lung","volume":"32","author":"Bazzani","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.12.029_bb0215","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1021\/mp900247d","article-title":"Comparison of the type of liposome involving cytokine production induced by non-CpG lipoplex in macrophages","volume":"7","author":"Yasuda","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2012.10.018","article-title":"Reduced in vitro and in vivo toxicity of siRNA-lipoplexes with addition of polyglutamate","volume":"165","author":"Schlegel","year":"2013","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0225","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.nano.2013.12.003","article-title":"Cationic lipid nanocarriers activate Toll-like receptor 2 and NLRP3 inflammasome pathways","volume":"10","author":"Lonez","year":"2014","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0230","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.addr.2012.05.009","article-title":"Cationic lipids activate intracellular signaling pathways","volume":"64","author":"Lonez","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0235","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1006\/bbrc.1994.2372","article-title":"A novel cationic amphiphile for transfection of mammalian cells","volume":"203","author":"Ruysschaert","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0240","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-015-1915-1","article-title":"Critical residues involved in Toll-like receptor 4 activation by cationic lipid nanocarriers are not located at the lipopolysaccharide-binding interface","author":"Lonez","year":"2015","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0245","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.plipres.2008.03.002","article-title":"Cationic liposomal lipids: from gene carriers to cell signaling","volume":"47","author":"Lonez","year":"2008","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0250","doi-asserted-by":"crossref","first-page":"8160","DOI":"10.1016\/j.biomaterials.2012.07.044","article-title":"A biomimetic lipid library for gene delivery through thiol-yne click chemistry","volume":"33","author":"Li","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.12.029_bb0255","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.biomaterials.2015.11.017","article-title":"The influence of the polar head-group of synthetic cationic lipids on the transfection efficiency mediated by niosomes in rat retina and brain","volume":"77","author":"Ojeda","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.12.029_bb0260","doi-asserted-by":"crossref","first-page":"5231","DOI":"10.1016\/j.biomaterials.2011.03.059","article-title":"The influence of the structural orientation of amide linkers on the serum compatibility and lung transfection properties of cationic amphiphiles","volume":"32","author":"Srujan","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.12.029_bb0265","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/0006-291X(91)91366-K","article-title":"A novel cationic liposome reagent for efficient transfection of mammalian cells","volume":"179","author":"Gao","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0270","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jconrel.2015.10.045","article-title":"Composites of malonic acid diamides and phospholipids\u2013impact of lipoplex stability on transfection efficiency","volume":"220","author":"Janich","year":"2015","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0275","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jconrel.2015.10.024","article-title":"siRNA-lipid nanoparticles with long-term storage stability facilitate potent gene-silencing in vivo","volume":"220","author":"Suzuki","year":"2015","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0280","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1472-6750-3-14","article-title":"Coupling of importin beta binding peptide on plasmid DNA: transfection efficiency is increased by modification of lipoplex's physico-chemical properties","volume":"3","author":"Carri\u00e8re","year":"2003","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0285","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1021\/bc049971k","article-title":"A new triantennary galactose-targeted PEGylated gene carrier, characterization of its complex with DNA, and transfection of hepatoma cells","volume":"15","author":"Frisch","year":"2004","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0290","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.bbagen.2009.01.005","article-title":"How to make siRNA lipoplexes efficient? Add a DNA cargo","volume":"1790","author":"Rhinn","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2016.12.029_bb0295","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1021\/jm9704964","article-title":"Synthesis, activity, and structure\u2013activity relationship studies of novel cationic lipids for DNA transfer","volume":"41","author":"Byk","year":"1998","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0300","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1002\/art.21876","article-title":"Efficient new cationic liposome formulation for systemic delivery of small interfering RNA silencing tumor necrosis factor alpha in experimental arthritis","volume":"54","author":"Khoury","year":"2006","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.jconrel.2016.12.029_bb0305","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0005-2736(97)00194-6","article-title":"Cationic lipid-mediated gene transfer: effect of serum on cellular uptake and intracellular fate of lipopolyamine\/DNA complexes","volume":"1368","author":"Escriou","year":"1998","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0310","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-012-1245-5","article-title":"Activation of innate immunity by lysozyme fibrils is critically dependent on cross-\u03b2 sheet structure","volume":"70","author":"Gustot","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0315","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.4049\/jimmunol.181.2.1245","article-title":"Elucidation of the MD-2\/TLR4 Interface required for signaling by lipid IVa","volume":"181","author":"Walsh","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0320","article-title":"Comparative protein structure modeling using MODELLER","volume":"47","author":"Webb","year":"2014"},{"key":"10.1016\/j.jconrel.2016.12.029_bb0325","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.cell.2007.09.008","article-title":"Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide","volume":"130","author":"Jin","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2016.12.029_bb0330","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1093\/nar\/gkg512","article-title":"CASTp: computed atlas of surface topography of proteins","volume":"31","author":"Binkowski","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0335","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0340","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF chimera\u2013a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0345","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1021\/ci200227u","article-title":"LigPlot+: multiple ligand-protein interaction diagrams for drug discovery","volume":"51","author":"Laskowski","year":"2011","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0350","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1046\/j.1462-5822.2003.00356.x","article-title":"Stimulation of human toll-like receptor (TLR) 2 and TLR6 with membrane lipoproteins of mycoplasma fermentans induces apoptotic cell death after NF-kappa B activation","volume":"6","author":"Into","year":"2004","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0355","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1177\/09680519040100060701","article-title":"Use of murine embryonic fibroblasts to define Toll-like receptor activation and specificity","volume":"10","author":"Kurt-Jones","year":"2004","journal-title":"J. Endotoxin Res."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0360","doi-asserted-by":"crossref","first-page":"9049","DOI":"10.1074\/jbc.M512525200","article-title":"TLR1- and TLR6-independent recognition of bacterial lipopeptides","volume":"281","author":"Buwitt-Beckmann","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0365","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2174\/156720105774370230","article-title":"Lipid carriers for gene therapy","volume":"2","author":"Hart","year":"2005","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0370","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1208\/s12249-012-9857-5","article-title":"Structure relationship of cationic lipids on gene transfection mediated by cationic liposomes","volume":"13","author":"Paecharoenchai","year":"2012","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2016.12.029_bb0375","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1021\/bc049934t","article-title":"Gene-transferring efficiencies of novel diamino cationic lipids with varied hydrocarbon chains","volume":"15","author":"Kim","year":"2004","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0380","unstructured":"Lipofectamine\u00ae Reagent, (n.d.). https:\/\/www.thermofisher.com\/uk\/en\/home\/brands\/product-brand\/lipofectamine.html (accessed November 21, 2016)."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0385","unstructured":"E.R. Lee, D.J. Harris, C.S. Siegel, S.H. Cheng, S.J. Eastman, J. Marshall, R.K. Scheule, Cationic amphiphiles containing spermine or spermidine cationic group for intracellular delivery of therapeutic molecules, US5783565 A, 1998. http:\/\/www.google.co.in\/patents\/US5783565 (accessed November 21, 2016)."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0390","unstructured":"Lipid products | MVL5 | 890000, (n.d.). https:\/\/avantilipids.com\/product\/890000\/ (accessed November 21, 2016)."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0395","unstructured":"M.J. Hope, S.C. Semple, J. Chen, T.D. Madden, P.R. Cullis, M.A. Ciufolini, B.L.S. Mui, Amino lipids and methods for the delivery of nucleic acids, US9139554 B2, 2015. http:\/\/www.google.ch\/patents\/US9139554 (accessed November 21, 2016)."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0400","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/jgm.166","article-title":"Enhanced in vitro and in vivo cationic lipid-mediated gene delivery with a fluorinated glycerophosphoethanolamine helper lipid","volume":"3","author":"Boussif","year":"2001","journal-title":"J. Gene Med."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0405","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1023\/A:1020342523694","article-title":"Formation of plasmid-based transfection complexes with an acid-labile cationic lipid: characterization of in vitro and in vivo gene transfer","volume":"19","author":"Boomer","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0410","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.immuni.2009.09.018","article-title":"Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer","volume":"31","author":"Kang","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2016.12.029_bb0415","doi-asserted-by":"crossref","first-page":"6354","DOI":"10.1111\/j.1742-4658.2005.05029.x","article-title":"Lipopeptide structure determines TLR2 dependent cell activation level","volume":"272","author":"Buwitt-Beckmann","year":"2005","journal-title":"FEBS J."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0420","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1016\/j.vaccine.2003.11.074","article-title":"Synthetic lipopeptide adjuvants and toll-like receptor 2\u2013structure-activity relationships","volume":"22","author":"Spohn","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2016.12.029_bb0425","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1128\/IAI.72.3.1657-1665.2004","article-title":"Relationship between structures and biological activities of mycoplasmal diacylated lipopeptides and their recognition by Toll-like receptors 2 and 6","volume":"72","author":"Okusawa","year":"2004","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0430","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1002\/1521-4141(2002012)32:12<3337::AID-IMMU3337>3.0.CO;2-I","article-title":"Differential recognition of structural details of bacterial lipopeptides by toll-like receptors","volume":"32","author":"Morr","year":"2002","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0435","unstructured":"CL419: TLR2 ligand & nucleic acid carrier derived from Pam2CSK4, (n.d.). http:\/\/www.invivogen.com\/cl419 (accessed September 6, 2015)."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0440","doi-asserted-by":"crossref","first-page":"36616","DOI":"10.1074\/jbc.M504320200","article-title":"Domain exchange between human toll-like receptors 1 and 6 reveals a region required for lipopeptide discrimination","volume":"280","author":"Omueti","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0450","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1126\/science.1139111","article-title":"Crystal structures of human MD-2 and its complex with antiendotoxic lipid IVa","volume":"316","author":"Ohto","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2016.12.029_bb0455","doi-asserted-by":"crossref","first-page":"7421","DOI":"10.1073\/pnas.1201193109","article-title":"Structural basis of species-specific endotoxin sensing by innate immune receptor TLR4\/MD-2","volume":"109","author":"Ohto","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0460","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/nature07830","article-title":"The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex","volume":"458","author":"Park","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2016.12.029_bb0465","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.molimm.2014.06.034","article-title":"The molecular mechanism of species-specific recognition of lipopolysaccharides by the MD-2\/TLR4 receptor complex","volume":"63","author":"Oblak","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0470","doi-asserted-by":"crossref","first-page":"8695","DOI":"10.1074\/jbc.M109.075127","article-title":"MD-2-mediated ionic interactions between lipid A and TLR4 are essential for receptor activation","volume":"285","author":"Meng","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0475","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1084\/jem.20071164","article-title":"Mannose-binding lectin enhances Toll-like receptors 2 and 6 signaling from the phagosome","volume":"205","author":"Ip","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0480","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.1128\/IAI.71.10.5541-5548.2003","article-title":"Pneumococcal lipoteichoic acid (LTA) is not as potent as staphylococcal LTA in stimulating Toll-like receptor 2","volume":"71","author":"Han","year":"2003","journal-title":"Infect. Immun."},{"issue":"185","key":"10.1016\/j.jconrel.2016.12.029_bb0485","first-page":"3708","article-title":"Internalization and coreceptor expression are critical for TLR2-mediated recognition of lipoteichoic acid in human peripheral blood","volume":"1950","author":"Bunk","year":"2010","journal-title":"J. Immunol. Baltim. Md"},{"key":"10.1016\/j.jconrel.2016.12.029_bb0490","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/09687860600790537","article-title":"Immunostimulation of dendritic cells by cationic liposomes","volume":"23","author":"Vangasseri","year":"2006","journal-title":"Mol. Membr. Biol."},{"key":"10.1016\/j.jconrel.2016.12.029_bb0495","doi-asserted-by":"crossref","first-page":"11018","DOI":"10.1073\/pnas.1502026112","article-title":"Structural basis for inhibition of TLR2 by staphylococcal superantigen-like protein 3 (SSL3)","volume":"112","author":"Koymans","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365916307374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365916307374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T13:30:17Z","timestamp":1718976617000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365916307374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":98,"alternative-id":["S0168365916307374"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2016.12.029","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toll-like receptor 2 promiscuity is responsible for the immunostimulatory activity of nucleic acid nanocarriers","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2016.12.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}